# Andera Partners' Biotech Investments: 24 Startups in Its Portfolio (2026) > The 24 Biotech startups Andera Partners has backed, by stage: $2.9B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/andera-partners-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series C and later 9 - [Tubulis](https://millionrounds.com/company/tubulis) - [Nouscom](https://millionrounds.com/company/nouscom) - [AM Pharma](https://millionrounds.com/company/am-pharma) - [*AP* Amolyt Pharma](https://millionrounds.com/company/amolyt-pharma) - [ReViral](https://millionrounds.com/company/reviral) - [AgomAB Therapeutics](https://millionrounds.com/company/agomab-therapeutics) - [Dynacure](https://millionrounds.com/company/dynacure) - [Cyllene Therapeutics](https://millionrounds.com/company/cyllene-therapeutics) - [ENYO Pharma](https://millionrounds.com/company/enyo-pharma) ## Series A 8 - [Arvelle Therapeutics](https://millionrounds.com/company/arvelle-therapeutics) - [Alveus Therapeutics Inc.](https://millionrounds.com/company/alveus-therapeutics-inc) - [Adcytherix](https://millionrounds.com/company/adcytherix) - [SciRhom](https://millionrounds.com/company/scirhom) - [Spiro Medical](https://millionrounds.com/company/spiro-medical) - [*GP* Genoa Pharmaceuticals](https://millionrounds.com/company/genoa-pharmaceuticals) - [Dualyx](https://millionrounds.com/company/dualyx) - [Ariceum Therapeutics](https://millionrounds.com/company/ariceum-therapeutics) ## Series B 5 - [FIRE1](https://millionrounds.com/company/fire1) - [Greywolf Therapeutics](https://millionrounds.com/company/grey-wolf-therapeutics) - [ImCheck Therapeutics](https://millionrounds.com/company/imcheck-therapeutics) - [Artios](https://millionrounds.com/company/artios) - [*C* Corvidia](https://millionrounds.com/company/corvidia) ## Stage not reported 2 - [Evommune](https://millionrounds.com/company/evommune) - [Inotrem](https://millionrounds.com/company/inotrem) ## Segment by segment ### Series C and later 9 startups · $1.4B raised - [**Tubulis**](https://millionrounds.com/company/tubulis) Tubulis is a chemotherapeutic medication developer specializing in cancer and chronic disease treatment. Germany $401M - [**Nouscom**](https://millionrounds.com/company/nouscom) Nouscom is a clinical-stage immuno-oncology company founded in 2015 and based in Basel, Switzerland, with operational facilities i Switzerland $191M - [**AM Pharma**](https://millionrounds.com/company/am-pharma) AM-Pharma is a Dutch clinical-stage biopharmaceutical company founded in 2001 and based in Utrecht, Netherlands. Netherlands $189M - [*AP* **Amolyt Pharma**](https://millionrounds.com/company/amolyt-pharma) Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders. France $139M - [**ReViral**](https://millionrounds.com/company/reviral) ReViral is a biotechnology company that develops and offers antiviral therapies for patients. United Kingdom $122M - [**AgomAB Therapeutics**](https://millionrounds.com/company/agomab-therapeutics) AgomAb Therapeutics is a Company is developing growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues. Belgium $112M - [**Dynacure**](https://millionrounds.com/company/dynacure) Dynacure is a clinical-stage drug development company focused on improving the lives of patients with rare and orphan diseases. France $109M - [**Cyllene Therapeutics**](https://millionrounds.com/company/cyllene-therapeutics) EG 427, operating under the name Cyllene Therapeutics, is a biotechnology company based in Paris. France $66M ### Series A 8 startups · $809M raised - [**Arvelle Therapeutics**](https://millionrounds.com/company/arvelle-therapeutics) Arvelle Therapeutics is a biopharmaceutical company with the mission of bringing innovative solution. Switzerland $223M - [**Alveus Therapeutics Inc.**](https://millionrounds.com/company/alveus-therapeutics-inc) Alveus Therapeutics Inc is a clinical-stage biotechnology company focused on developing innovative therapies for obesity and metab United States $197M - [**Adcytherix**](https://millionrounds.com/company/adcytherix) Adcytherix is a clinical-stage biopharmaceutical company based in Marseille, France. France $122M - [**SciRhom**](https://millionrounds.com/company/scirhom) SciRhom GmbH is a biotechnology company based in Martinsried, Germany, founded in 2016. Germany $68M - [**Spiro Medical**](https://millionrounds.com/company/spiro-medical) Spiro Medical is a medical device company developing a groundbreaking Pulmonary Neuromodulation (PNM) System for asthma treatment. United States $67M - [*GP* **Genoa Pharmaceuticals**](https://millionrounds.com/company/genoa-pharmaceuticals) Genoa Pharmaceuticals developes improved therapies for the treatment of Idiopathic Pulmonary Fibrosis (IPF). United States $63M - [**Dualyx**](https://millionrounds.com/company/dualyx) Dualyx is a biotechnology company based in Zwijnaarde, Ghent, Belgium, focused on developing novel therapies for autoimmune diseases. Belgium $44M - [**Ariceum Therapeutics**](https://millionrounds.com/company/ariceum-therapeutics) Ariceum Therapeutics is a private, clinical-stage radiopharmaceutical company based in Berlin, Germany. Germany $25M ### Series B 5 startups · $555M raised - [**FIRE1**](https://millionrounds.com/company/fire1) FIRE1, officially known as The Foundry Innovation and Research 1, Ltd., is a connected medical device company based in Dublin, Ireland. Ireland $170M - [**Greywolf Therapeutics**](https://millionrounds.com/company/grey-wolf-therapeutics) Greywolf Therapeutics is a clinical-stage biotechnology company based in Oxford, United Kingdom. United Kingdom $144M - [**ImCheck Therapeutics**](https://millionrounds.com/company/imcheck-therapeutics) ImCheck Therapeutics is a developing novel therapeutics that target members of the butyrophilin (BTN) super-family of checkpoint molecules. France $97M - [**Artios**](https://millionrounds.com/company/artios) Artios Pharma Limited is a privately held biotechnology company based in Cambridge, United Kingdom, at the Babraham Research Campus. United Kingdom $83M - [*C* **Corvidia**](https://millionrounds.com/company/corvidia) Corvidia Therapeutics focuses on the research and development of transformative therapies for cardio-renal diseases. United States $61M ### Stage not reported 2 startups · $191M raised - [**Evommune**](https://millionrounds.com/company/evommune) Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms. United States $125M - [**Inotrem**](https://millionrounds.com/company/inotrem) Inotrem is a French biotechnology company founded in 2013, based in Paris with a technology center in Nancy. France $66M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Andera Partners as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Co-investors **Who invests with Andera Partners** 25 co-investors](https://millionrounds.com/portfolio-maps/andera-partners-co-investors)[Sector portfolio **Eurazeo's AI portfolio** 23 startups · $10B](https://millionrounds.com/portfolio-maps/eurazeo-ai-portfolio)[Sector portfolio **Idinvest Partners' Biotech portfolio** 20 startups · $994M](https://millionrounds.com/portfolio-maps/idinvest-partners-biotech-portfolio)[Sector portfolio **Demeter's Agtech portfolio** 11 startups · $100M](https://millionrounds.com/portfolio-maps/demeter-agtech-portfolio)[Sector portfolio **Y Combinator's AI portfolio** 1,143 startups · $44B](https://millionrounds.com/portfolio-maps/y-combinator-ai-portfolio)[Sector portfolio **Y Combinator's Fintech portfolio** 338 startups · $24B](https://millionrounds.com/portfolio-maps/y-combinator-fintech-portfolio) ## Raising from investors like Andera Partners? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)